HuR deficiency abrogated the enhanced NLRP3 signaling in experimental ischemic stroke

Author:

Wang Xiaojie1ORCID,Zhao Mingfeng2ORCID,Lu Xiulian3ORCID,Du Pengchao4ORCID,Feng Shaobin5ORCID,Gong Ruo3ORCID,Chen Hao5ORCID,Qi Guoliang5ORCID,Yang Fan5ORCID

Affiliation:

1. Department of Pharmacology, School of Basic Medical Sciences Shandong University Jinan China

2. Department of Pathology Binzhou Medical University Binzhou China

3. Cisen Pharmaceutical Co., Ltd Jining China

4. Institute of Pathology and Pathophysiology, School of Basic Medical Sciences Binzhou Medical University Yantai China

5. Department of Neurosurgery Shandong Provincial Hospital Affiliated to Shandong First Medical University Jinan China

Abstract

AbstractHuman antigen R (HuR) is a universally expressed RNA‐binding protein that plays an essential role in governing the fate of mRNA transcripts. Accumulating evidence indicated that HuR is involved in the development and functions of several cell types. However, its role in cerebral ischemia/reperfusion injury (CIRI) remains unclear. In this study, we found that HuR was significantly upregulated after CIRI. Moreover, we found that silencing HuR could inhibit the inflammatory response of microglia and reduce the damage to neurons caused by oxygen–glucose deprivation/reperfusion treatment. In vivo, we found that microglial HuR deficiency significantly ameliorated CIRI and reduced NLRP3‐mediated inflammasome activation. Mechanistically, we found that HuR could regulate NLRP3 mRNA stability by binding to the AU‐rich element (ARE) region within the 3′ untranslated region (UTR) of NLRP3 mRNA. In addition, we found that the upregulation of HuR was dependent on the upregulation of NADPH oxidase‐mediated ROS accumulation. Collectively, our studies revealed that HuR could regulate NLRP3 expression and that HuR deficiency abrogated the enhanced NLRP3 signaling in experimental ischemic stroke. Targeting HuR may be a novel therapeutic strategy for cerebral ischemic stroke treatment.

Funder

Natural Science Foundation of Shandong Province

Publisher

Wiley

Subject

Genetics,Molecular Biology,Biochemistry,Biotechnology

Cited by 1 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3